Modifiable Determinants of Morbidity and Failure After Mid-Urethral Sling Surgery: Medium-Term Analysis of 3,671 Procedures

FRITEL X1, CAMPAGNE-LOISEAU S2, LECLERE M3, ANSOLABEHERE X3, FERRY P4, SAUSSINE C5, COSSON M6, BOSSET P7, CURINIER S2, CAPON G8, DEFFIEUX X9, LECORNET E10, PANEL L11, LUCOT J12, WAGNER L13, de TAYRAC R13, FAUCONNIER A14

Research Type

Clinical

Abstract Category

Female Stress Urinary Incontinence (SUI)

Abstract 748
Open Discussion ePosters
Scientific Open Discussion Session 108
Friday 9th October 2026
13:35 - 13:40 (ePoster Station 2)
Exhibition Hall
Female Grafts: Synthetic Stress Urinary Incontinence Surgery
1. Université de Poitiers, 2. CHU Estaing, 3. Clinityx, 4. CH La Rochelle, 5. CHRU Strasbourg, 6. CHRU Lille, 7. Hôpital Foch, 8. CHU Bordeaux, 9. APHP Antoine-Béclère, 10. AHNAC, 11. Clinique Beausoleil, 12. Hôpital Saint-Vincent, 13. CHU Carémeau, 14. CHI Poissy-Saint-Germain
Presenter
Links

Abstract

Hypothesis / aims of study
In female stress urinary incontinence (SUI) treated with mid-urethral slings (MUS), reducing morbidity and failure rate need assessing modifiable determinants related to surgical practice or sling properties (weight, elasticity). Clarifying whether surgical volume influences complication risk could inform potential regulation.
Our aim was to analyse the modifiable determinants of complications and recurrences based on known or identified risk factors in our registry, which was linked to health insurance data.
Study design, materials and methods
This analysis covers patients included in our registry  who received a midurethral sling for female stress urinary incontinence by the retropubic or transobturator route [1]. The data used in the main analysis were drawn from the registry [1] for the identification of the sling and from the health insurance database for the outcomes. Risk factors will be categorised into three domains (medical history / index surgery and characteristics of the implanted sling / surgical centre; see Table 1). 
A complication was defined as any surgical procedure to transect or remove the sling. A recurrence was defined as any further surgical procedure for urinary incontinence.
The explanatory analysis of surgical complications and recurrences is based on a Cox model with frailty, allowing for intra-centre correlation and the prioritisation of variables according to their individual level (level 1) or centre-related level (level 2, see Table 1). 
Prior to variables selection, a dimension reduction and variable pre-selection step is carried out using Principal Component Analysis performed for each domain. This will identify relevant combinations to include in the multivariate analyses and reduce the dimensionality of correlated variables, particularly those describing the characteristics of the sling. 
The analysis is conducted in three stages: 1) univariate models adjusted for age and the Charlson score for level 1 variables; 2) univariate models for centre (level 2) variables; 3) final multivariate model.
Results
We identified 3,671 MUS insertions across 37 surgical centres between 2017 and 2020. The mean age of the women at surgery was 57 years. Eleven women were transferred to a continuous care unit following sling insertion; no deaths were reported during their hospital stay. The median follow-up period was 1,082 days (almost 3 years). The prevalence of complications leading to sectioning or removal of the sling was 4.0% (148/3671), and the prevalence of SUI recurrence requiring further surgery was 4.2% (156/3671). 
Level 1 univariate analyses (patient characteristics, sling properties and surgical procedure) showed that the following variables significantly increased the risk of complications: chronic disease, a history of surgery for SUI or POP, continue use of pain medication, the retropubic route, the weight and the elasticity of the sling. 
The following variables increased the risk of recurrence: the woman’s age at surgery, a history of surgery for SUI or POP, the retropubic route, and associated surgical procedures (hysterectomy or prolapse repair).
Further multivariate analyses are currently underway and will be presented at the congress.
Interpretation of results
Our work in routine clinical practice should help to identify the modifiable risk factors for complications and recurrence.
Concluding message
Our analysis could help to inform patients, guide the choice of surgical unit and regulate surgical activity.
Figure 1 Table 1. Explanatory variables analysed and outcome measures
References
  1. Armengaud et al. Serious complications and recurrences after retropubic versus transobturator midurethral sling procedures for 2682 patients in the VIGI-MESH register. Am J Obstet Gynecol 2024;230:428.e1-428.e13. doi: 10.1016/j.ajog.2023.11.124
  2. Bannay et al. The Best Use of the Charlson Comorbidity Index With Electronic Health Care Database to Predict Mortality. Med Care 2016;54:188–94.
Disclosures
Funding ANSM (French National Agency for Medicines and Health Products Safety), Johnson & Johnson, BOSTON Scientific, COLOPLAST, ABISS, THT bioscience Clinical Trial No Subjects Human Ethics Committee Comité de Protection des Personnes Ouest III, France Helsinki Yes Informed Consent Yes AI For simple textual assistance in writing the abstract manuscript
09/09/2026 18:43:40